SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,094.64 166.49
( 0.21%)

Global Indices

Nasdaq

52,497.89 268.83
(0.51%)

Dow Jones

7,510.69 52.06
(0.70%)

Hang Seng

64,316.33 2,448.90
(3.96%)

Nikkei 225

10,879.26 -18.01
(-0.17%)

Forex

USD-INR

95.59 -0.10
(-0.11%)

EUR-INR

109.79 0.65
(0.59%)

GBP-INR

128.11 0.75
(0.59%)

JPY-INR

0.59 0.01
(1.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

49.51

44951.04

EPS(TTM)

Face Value()

Div & Yield %

53.59

2.15

Back

glaxosmithkline pharmaceuticals ltd

Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter

Feb 09,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1041.26	949.42	10
OPM %	35.66	30.75	-
PBDT	402.27	326.90	23
PBT	381.95	308.10	24
NP	295.62	229.88	29

78,094.64 166.49 ( 0.21%)

52,497.89 268.83 (0.51%)

7,510.69 52.06 (0.70%)

64,316.33 2,448.90 (3.96%)

10,879.26 -18.01 (-0.17%)

95.59 -0.10 (-0.11%)

109.79 0.65 (0.59%)

128.11 0.75 (0.59%)

0.59 0.01 (1.09%)